文献速递中医内科针灸推拿

电针联合艾灸治疗重性抑郁障碍:随机假对照预试验

Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial.
PubMed 文献 · Integr Med Res · 2021-04-23

主要结局为基线至第9周HRSD总分变化组间差异,结果未达显著(p=0.2641),两组HRSD均显著改善,不良事件发生率组间无显著差异(p=0.1067)。结论认为该疗法可行,但需更大样本和理想对照的进一步研究确认疗效与安全性。

要点

  • 电针联合艾灸治疗重性抑郁障碍在预试验中显示可行。
  • 主要结局HRSD总分变化组间差异无统计学意义(p=0.2641)。
  • 两组不良事件发生率无显著差异(p=0.1067)。

核心结论

  • 电针联合艾灸治疗重性抑郁障碍的临床试验似乎可行。
  • 需更大样本、采用理想对照的进一步研究才能得出疗效与安全性的确证性结论。

研究设计与样本

  • 治疗组接受电针联合艾灸,对照组在非穴位接受假干预,疗程8周。

主要发现

  • 主要结局指标基线至第9周HRSD总分平均变化组间差异无统计学意义(p=0.2641)。
  • 两组HRSD评分治疗后均显著改善。
  • 次要结局指标组间均无显著差异。
  • 不良事件发生率组间无显著差异(p=0.1067)。

临床怎么用

  • 该预试验提示电针联合艾灸治疗重性抑郁障碍可行,但疗效尚未证实,临床决策需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The first treatment option for major depressive disorder (MDD) is antidepressants, however, there is substantial demand for alternative therapies due to its low compliance and remission rates. This study was aimed to explore the effectiveness, safety, and feasibility of electroacupuncture plus moxibustion therapy for MDD. METHODS: Thirty adults with MDD were randomly assigned to the treatment group (TG) or control group (CG). The TG was treated with electroacupuncture plus moxibustion, and the CG received sham interventions at non-acupoints for 8 weeks. The primary outcome measure was the intergroup difference of the mean change of total score of the Hamilton rating scale for depression (HRSD) between baseline and week 9. Secondary outcome measures were Beck's depression inventory, insomnia severity index, the state-trait anxiety inventory, the EuroQol-5 dimension index, the measure yourself medical outcome profile version 2, and frontal alpha asymmetry measured by electroencephalography. Adverse events (AEs) were monitored for safety assessment. RESULTS: The primary outcome measure was not significantly different between the two groups (p=0.2641), although the scores of HRSD in both groups improved significantly after treatment. No significant difference was identified between groups in secondary outcome measures. The incidence of AE was not significantly different between the two groups (p=0.1067). CONCLUSION: A clinical trial using electroacupuncture plus moxibustion for MDD seems feasible. However, further studies with the larger size, adopting ideal controls are warranted to provide a confirmative conclusion to the efficacy and safety of electroacupuncture plus moxibustion for MDD.

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Kim M, Choi EJ, Kwon OJ, et al. Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial. Integr Med Res. 2021. PMID: 34307020. doi:10.1016/j.imr.2021.100727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。